H3K4 TRIMETHYLATION IS A TARGETABLE DEPENDENCY IN T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL)

EHA Library, Gabriela Segat, 4160406

CD4+ CADM1+ T CELL POPULATION EMERGES AS A MALIGNANCY-ASSOCIATED BIOMARKER IN EBV-RELATED LYMPHOPROLIFERATIVE DISORDERS

EHA Library, Qinhuan Luo, 4161062

PROTEOMIC PROFILING USING HIGH-DIMENSIONAL MULTIPLEX PLATFORMS TO IDENTIFY PROSPECTIVE RISK FACTORS FOR LYMPHOID MALIGNANCIES ACROSS MULTIPLE COHORTS

EHA Library, Pieter Martijn Kolijn, 4161064

ASSESSMENT OF CIRCULATING TUMOR DNA (CTDNA) FOR RESPONSE PREDICTION AND GENETIC CHARACTERIZATION OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL) RECEIVING GLOFITAMAB TREATMENT

EHA Library, Chiara Signori, 4161065

EMBRYONIC ECTODERM DEVELOPMENT (EED) INHIBITOR APG-5918 EXHIBITS POTENT ANTITUMOR ACTIVITY AND SYNERGIZES WITH HISTONE DEACETYLASE INHIBITOR TUCIDINOSTAT IN PRECLINICAL T-CELL LYMPHOMA (TCL) MODELS

EHA Library, Eric Liang, 4161067

A GENOME-WIDE CRISPR SCREEN IDENTIFIES UBE2A LOSS-OF-FUNCTION TO CONFER BORTEZOMIB SENSITIVITY IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Hanne DUE, 4161068

ADVANTIG-101: A PHASE 1B/2 STUDY OF OCIPERLIMAB (ANTI-TIGIT) PLUS TISLELIZUMAB (ANTI-PD-1) OR RITUXIMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Yuqin Song, 4161069

RACIAL AND CLINICAL DETERMINANTS OF RESPONSE IN 2,304 RELAPSE/REFRACTORY B-CELL LYMPHOMAS TREATED WITH ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELL IN CLINICAL TRIALS

EHA Library, Soon Jye Kho, 4161070

COMPREHENSIVE ANALYSIS OF MUTATIONAL SIGNATURES IN PATIENTS WITH RELAPSED/REFRACTORY LBCL BY CIRCULATING TUMOR DNA SEQUENCING

EHA Library, Sophie Heidenreich, 4161072

UNLOCKING THE POTENTIAL OF EXTRACELLULAR VESICLES: PREDICTIVE BIOMARKERS FOR IMMUNE HYPERACTIVITY AND ENDOTHELIAL DAMAGE FOLLOWING CAR-T CELLS.

EHA Library, Michele Dicataldo, 4161074

PREDICTIVE VALUE OF CTDNA AND MRD DYNAMICS IN DIFFUSE LARGE B-CELL LYMPHOMA: A PROSPECTIVE COHORT STUDY

EHA Library, Xiao Liu, 4161077

ANTITUMOR CHARACTERIZATION OF IPH6501, A NOVEL IL2V-ARMED TETRASPECIFIC NK CELL ENGAGER TARGETING CD20 B CELLS, IN DLBCL AND FL PATIENT SAMPLES, AND IN PRECLINICAL COMBINATION WITH R-CHOP

EHA Library, Florent Carrette, 4161078

GENOMIC TESTING IN PATIENTS WITH LARGE CELL AND FOLLICULAR LYMPHOMA TREATED WITH T-CELL ENGAGERS BI-SPECIFIC ANTIBODIES AND CORRELATION WITH TREATMENT RESPONSE

EHA Library, Rita Tavarozzi, 4161081

IMPACT OF LARGE B-CELL LYMPHOMA (LBCL) GENOMICS ON CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) TREATMENT OUTCOMES

EHA Library, Marc Bosch Schips, 4161083

SYSTEMS BIOLOGY-ENABLED TARGETING OF NF-κB AND BCL2 OVERCOMES MICROENVIRONMENT-MEDIATED BH3-MIMETIC RESISTANCE IN DLBCL

EHA Library, Aimilia VARELI, 4161085

THE ONCOGENIC FYN::TRAF3IP2 FUSION SHAPES THE TUMOR MICROENVIRONMENT IN PTCL-NOS

EHA Library, Yilke Schoenmaekers, 4161086

ABERRANT EXPRESSION AND ONCOGENIC ACTIVITY OF SPP1 IN HODGKIN LYMPHOMA

EHA Library, Stefan Nagel, 4161087

NOVEL IMMUNOPHENOTYPIC APPROACHES TO IMPROVE THE DIAGNOSTIC CLASSIFICATION OF MATURE T-CELL NEOPLASMS

EHA Library, Alberto Orfao, 4161088

A STUDY ON THE MECHANISM OF ACTION OF THE NOVEL HIGHLY SELECTIVE HDAC INHIBITOR PURINOSTAT MESYLATE IN DOUBLE-HIT LYMPHOMA AND ITS THERAPEUTIC POTENTIAL IN COMBINATION WITH VENETOCLAX

EHA Library, Jie Wang, 4161093

TO EXPLORE THE EFFECT AND MECHANISM OF ZANUBRUTINIB, LENALIDOMIDE, TEMOZOLOMIDE IN THE TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Rong Fu, 4161094

THE SIGNIFICANCE OF HLA PHYLOGENETICALLY RELATED COUNTRIES IN THE CREATION OF IPSC HAPLOBANKS AGAINST THE REGIONAL HLA HETEROGENEITY.

EHA Library, Helen Papadaki, 4161097

BONE MARROW SELENOP+ MACROPHAGES PROMOTE HEMATOPOIETIC RECONSTITUTION AFTER TRANSPLANTATION VIA GAS6-AXL SIGNALING PATHWAY

EHA Library, Mengzhu Shen, 4161098

GENETIC POLYMORPHISMS OF ENZYMES METABOLIZING CYCLOPHOSPHAMIDE IS ASSOCIATED WITH THE CLINICAL OUTCOMES OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Huai-Chueh Gem Wu, 4161099

STEARIC ACID-INDUCED MACROPHAGE PYROPTOSIS EXACERBATES THE SEVERITY OF AGVHD

EHA Library, Xue-Yan Sun, 4161100

A RANDOMIZED TRIAL OF THREE GVHD PROPHYLAXIS REGIMENS IN HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANT: ANTITHYMOCYTE GLOBULIN, POSTTRANSPLANT CYCLOPHOSPHAMIDE, AND LOW-DOSE COMBINATION THERAPY

EHA Library, Yannan Jia, 4161101

DYNAMIC IMMUNE RECONSTITUTION AND CLINICAL OUTCOMES OF THREE DIFFERENT PROTOCOLS FOR HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiao-Di Ma, 4161102

THE EFFECTS OF PRIOR LINES OF THERAPY ON CLINICAL OUTCOMES FOR PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE RECEIVING AXATILIMAB: A POST HOC ANALYSIS OF AGAVE-201

EHA Library, Valkal Bhatt, 4161103

MAAT033 TO ENSURE OPTIMAL GUT MICROBIOTA TO IMPROVE SURVIVAL IN PATIENTS? RECEIVING ALLOGENEIC HCT: PHOEBUS TRIAL

EHA Library, Natalia Gemperle Ortiz, 4161105

THE ROLE OF MAINTENANCE THERAPY FOLLOWING CAR T-CELL THERAPY IN LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, bingling guo, 4161109

NON-HLA LOSS-OF-FUNCTION VARIATIONS-BASED PREDICTIVE MODEL FOR ACUTE GRAFT-VERSUS-HOST DISEASE AFTER HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Keli Yue, 4161111

UNRELATED CORD BLOOD THERAPY: A PROMISING ALTERNATIVE FOR SEVERE APLASTIC ANEMIA

EHA Library, Fang Zhou, 4161112

EFFICACY ANALYSIS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 140 PEDIATRIC PATIENTS WITH KMT2A REARRANGEMENTS ACUTE MYELOID LEUKEMIA

EHA Library, Rui-juan sun, 4161113

ITALIAN RETROSPECTIVE REAL-LIFE ANALYSIS ON BELUMOSUDIL FOR TREATMENT-RESISTANT/REFRACTORY CHRONIC GVHD

EHA Library, Francesca Bonifazi, 4161116

MEASURABLE CYCLOPHOSPHAMIDE ON DAY 0 OF ALLOGENEIC STEM CELL TRANSPLANTATION ADVERSELY IMPACTS GRAFT-VERSUS-HOST DISEASE AND SURVIVAL OUTCOMES

EHA Library, Ray Mun Koo, 4161119

HYPOMETHYLATING AGENTS AND VENETOCLAX FOR RELAPSE PREVENTION IN PATIENTS WITH HIGH-RISK MYELOID MALIGNANCIES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Liping Wan, 4161121

THE HAPLOID HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH UMBILICAL CORD BLOOD TRANSFUSION IN THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES: A MULTICENTER, SINGLE-ARM PROSPECTIVE TRIAL

EHA Library, Xianbo Huang, 4161122

INVASIVE FUNGAL DISEASE IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH ANTIFUNGAL PROPHYLAXIS

EHA Library, cao jiaxin, 4161123

DYNAMIC IMMUNE RECONSTITUTION IN MIXED CHIMERISM: MECHANISMS LINKING TO GRAFT STABILITY AND CLINICAL OUTCOMES IN SEVERE APLASTIC ANEMIA AFTER HLA-MATCHED TRANSPLANTATION

EHA Library, Ming-Hao Lin, 4161124

ASSESSMENT OF CIRCULATING CELL FREE DNA AND CYTOKINE LEVELS IN HEMATOPOIETIC STEM CELL DONORS

EHA Library, Tatyana Rybolovleva, 4161126

A NOVEL CONDITIONING REGIMEN COMBINING SELINEXOR WITH MELPHALAN IMPROVES SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA:A PROSPECTIVE STUDY

EHA Library, Liangliang Ma, 4161128

COMPARISON OF THE 25 VS 50 MG/KG POST-TRANSPLANTATION CYCLOPHOSPHAMIDE DOSES IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

EHA Library, Turgay Ulas, 4161130

REDUCED TOXICITY CONDITIONGING REGIMEN CONTAINING DECITABINE IS FEASIBLE AND ACHIEVES COMPARABLE CLINICAL OUTCOME IN ELDERLY AND FRAGILE MDS PATIETNS RECEIVED STEM CELL TRANSPLATATION: A RETROSPECTIVE, SINGLE-CENTER ANALYSIS

EHA Library, yanling Ren, 4161131

CLINICAL EFFECTS OF RUNX1 MUTATIONS ON THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION

EHA Library, WeiJie Ran, 4161134

SURVIVAL BENEFIT OF ALLOGENEIC HSCT IN CMML PATIENTS DURING THE MOLECULAR STRATIFICATION ERA: A MULTICENTER COHORT STUDY

EHA Library, Rui Ma, 4161137

CONVALESCENT PLASMA THERAPY FOR COVID-19 PROPHYLAXIS IN ADULTS EARLY POST-HEMATOPOIETIC STEM CELL TRANSPLANTATION: ONE-YEAR OUTCOMES FROM A RANDOMIZED CONTROLLED TRIAL

EHA Library, Yigeng Cao, 4161138

DYNAMIC OUTCOME PREDICTION BY NT-PROBNP KINETICS FOLLOWING POST-TRANSPLANT CYCLOPHOSPHAMIDE-BASED GVHD PROPHYLAXIS

EHA Library, Niek van der Maas, 4161140

EFFICACY AND SAFETY OF RUXOLITINIB COMBINED WITH STEROIDS FOR FIRST-LINE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: A SINGLE-CENTER, REAL-WORLD EXPERIENCE

EHA Library, Yang Yan, 4161142

LONG TERM OUTCOME OF αßTCR/CD19 DEPLETED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULTS WITH ACUTE LEUKEMIA. A SINGLE CENTER EXPERIENCE.

EHA Library, Lucia Prezioso, 4161143

ESTABLISHING A NOVEL GI-GVHD PREDICTION MODEL BASED ON MAIT CELLS AND DONOR-RECIPIENT CLINICAL CHARACTERISTICS

EHA Library, Mengge Gao, 4161144

EXPOSURE RESPONSE OF RAVULIZUMAB TO TREAT PEDIATRIC PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION-ASSOCIATED THROMBOTIC MICROANGIOPATHY

EHA Library, Jonathan Monteleone, 4161146

REAL WORLD TREATMENT DURATION IN PATIENTS WITH CHRONIC GRAFT VERSUS HOST DISEASE RECEIVING BELUMOSUDIL COMPARED TO BEST AVAILABLE THERAPY (ROCKREAL)

EHA Library, Kevin Hall, 4161148

SIROLIMUS-STEROID COMBINATION VS. STEROID MONOTHERAPY AS FIRST-LINE TREATMENT FOR CHRONIC GVHD: A RANDOMIZED CONTROLLED TRIAL

EHA Library, Xi Zhang, 4161150

BREAKING AGE BARRIERS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: EXPLORING THE SAFETY AND EFFICACY OF POST-TRANSPLANT CYCLOPHOSPHAMIDE-BASED PROPHYLAXIS IN ADULTS ACCORDING TO AGE RANGES

EHA Library, Gorka Pinedo Martín, 4161152

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR DIAMOND-BLACKFAN ANEMIA: FAVORABLE OUTCOMES FROM A SINGLE CENTER

EHA Library, Lan He, 4161154

EXPANSION OF CYTOTOXIC T LYMPHOCYTES POST-ALLOGENEIC TRANSPLANT: FACTORS INVOLVED IN THEIR DEVELOPMENT AND IMPACT ON TRANSPLANT OUTCOMES

EHA Library, Jaime Ortiz Andrade, 4161155

SECOND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA IN THE ERA OF IMMUNOTHERAPY: OUTCOMES AND PROGNOSTIC RISK FACTORS

EHA Library, Rui Wang, 4161156

SINGLE-CENTER RETROSPECTIVE ANALYSIS OF THE PROGNOSIS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MLL-AF6 FUSION GENE POSITIVE ACUTE MYELOID LEUKEMIA

EHA Library, Xingyu Cao, 4161157

CLINICAL STUDY OF CLADRIBINE-CONTAINING CONDITIONING REGIMEN IN HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Yi Zhu, 4161158

TREOSULFAN-BASED CONDITIONING IN ALLO-HCT FOR OLDER ADULTS: LESS TOXICITY, LOWER ENDOTHELIAL ACTIVATION, AND COMPARABLE OUTCOMES

EHA Library, Maria Queralt Salas, 4161160

DUAL EPIGENETIC MODULATION: DECITABINE-AUGMENTED MYELOABLATIVE CONDITIONING WITH POST-HSCT LOW-DOSE HMA MAINTENANCE ACHIEVES 100% SURVIVAL WITH CLONAL ERADICATION IN PEDIATRIC GATA2 DEFICIENCY-ASSOCIATED MYELOID MALIGNANCIES

EHA Library, Yuanyuan Ren, 4161164

LONG NONCODING RNA MTAAT REGULATES PD-L1 SUBCELLULAR TRAFFICKING IN T-CELL LYMPHOMA THROUGH ARF6

EHA Library, Selene Mallia, 4161061

CLONAL HEMATOPOIESIS IN FOLLICULAR LYMPHOMA: ANALYSIS OF THE PHASE III FIL FOLL12 TRIAL

EHA Library, Riccardo Moia, 4161063

TARGETING MICRORNAS TO OVERCOME DRUG RESISTANCE IN DIFFUSE LARGE B-CELL LYMPHOMA: A FUNCTIONAL AND CLINICAL STUDY FOR THE DEVELOPMENT OF RNA-BASED COMPLEMENTARY THERAPIES.

EHA Library, Giulia Regazzo, 4161066

DISTINCT T-CELL PROFILES AND INSIGHTS INTO T-CELL RESPONSES IN SPLENIC SMALL B-CELL MALIGNANCIES

EHA Library, Elisavet Vlachonikola, 4161071

TRANSLATIONAL FINDINGS FROM THE PHASE 2 LUMINICE-203 STUDY OF ACIMTAMIG (AFM13) IN COMBINATION WITH ALLONK® (AB-101) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)

EHA Library, Joseph Maakaron, 4161073

PEMBROLIZUMAB THERAPY INDUCES AN INFLAMMATORY RESPONSE IN LYMPHOMA PATIENTS BY RESHAPING MONOCYTES RESULTING IN HYPERPROGRESSIVE DISEASE

EHA Library, Zhi-Zhang Yang, 4161075

ENDOCYTIC MODULATION UNVEILS A NOVEL MECHANISM OF NOTCH1 ACTIVATION IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Paolo Sportoletti, 4161076

LCP2 MEDIATES SUV39H1-DRIVEN CELLULAR SENESCENCE-RELATED CHEMORESISTANCE IN NATURAL KILLER/T CELL LYMPHOMA

EHA Library, Yue Zhang, 4161079

EXPERT-INDEPENDENT CLASSIFICATION OF T-CELL CHRONIC LYMPHOPROLIPHERATIVE DISORDERS USING STANDARDIZED FLOW CYTOMETRY

EHA Library, Sonia Carretero-Domínguez, 4161080

A DELICATE BALANCE BETWEEN EPSTEIN-BARR VIRUS (EBV) INDUCED MUTAGENESIS AND DNA REPAIR DICTATES STABILIZED LATENCY OR LYTIC POTENTIATION: IMPLICATIONS FOR EBV ASSOCIATED LYMPHOMAGENESIS

EHA Library, Tom Howard, 4161082

THE NOVEL ENHANCER-DERIVED LNCRNA U47924.31 SENSITIZES TO R-CHOP IMMUNO-CHEMOTHERAPY SERVING AS A NEW POTENTIAL THERAPEUTIC TARGET IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Giulia Vari, 4161084

COMPREHENSIVE EVALUATION OF OTHER IATROGENIC IMMUNODEFICIENCY-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE ELUCIDATES THE UNIQUE IMPACT OF METHOTREXATE-BASED IMMUNOSUPPRESSION AND EBV INFECTION

EHA Library, Yuki Furukawa, 4161089

PRE-INFUSION CD57+ CAR-T CELL FREQUENCY AND EARLY POST-INFUSION PD-1 EXPRESSION CORRELATE WITH CLINICAL OUTCOMES FOLLOWING CAR-T CELL THERAPY FOR HEMATOLOGICAL MALIGNANCIES

EHA Library, yajing zhang, 4161090

DETECTION OF CHROMOSOMAL REARRANGEMENTS IN PEDIATRIC T-LYMPHOBLASTIC LYMPHOMA USING HI-C-SEQUENCING

EHA Library, Vlada Tuliavko, 4161091

DEVELOPMENT OF PATIENT-DERIVED 3D LYMPHOMA CULTURE MODELS FOR PERSONALIZAED TREATMENT EVALUATION

EHA Library, Ana Belén Arroyo-Rodríguez, 4161092

POLYMORPHONUCLEAR MYELOID-DERIVED SUPPRESSOR CELLS REPROGRAM FATTY ACID METABOLISM TO INDUCE IMMUNOSUPPRESSION IN PATIENTS RECEIVING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Yujun Wei, 4161095

PREVALENCE AND ORIGINS OF CLONAL HEMATOPOIESIS IN LONG-TERM SURVIVORS OF PEDIATRIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Mirjam Belderbos, 4161096

DROPLET DIGITAL PCR FOR MRD MONITORING STANDS AS A PROMISING APPROACH IN PREDICTING RELAPSE AT THE EARLIEST FOR PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiao Zhou, 4161104

CHIDAMIDE MONOTHERAPY PREVENTS THE RELAPSE OF HIGH-RISK MYELOID MALIGNANCIES POST-ALLO-HSCT: A PROSPECTIVE, SINGLE-CENTER, PHASE I/II TRIAL

EHA Library, Qiushi Liang, 4161106

RANDOMIZED TRIAL OF ANTI-THYMOCYTE GLOBULIN PLUS LOW-DOSE POSTTRANSPLANT CYCLOPHOSPHAMIDE FOR GVHD PREVENTION IN HAPLOIDENTICAL TRANSPLANTATION

EHA Library, Yu Wang, 4161107

UNMET NEEDS IN CHRONIC GRAFT-VERSUS-HOST DISEASE MANAGEMENT: FRENCH SUBSET ANALYSIS OF EUROPEAN PATIENTS WHO PREVIOUSLY RECEIVED 2 TO 5 LINES OF THERAPY

EHA Library, Darko Kiprijanovski, 4161108

G-CSF-PRIMED PERIPHERAL BLOOD STEM CELL HAPLOIDENTICAL TRANSPLANTATION COULD ACHIEVE SATISFACTORY CLINICAL OUTCOMES FOR SEVERE APLASTIC ANEMIA PATIENTS

EHA Library, Xiao-Di Ma, 4161110

ROLE OF PRE-TRANSPLANT PCR ON CLINICAL OUTCOME IN CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA

EHA Library, Yu-sin Wu, 4161114

GERIATRIC ASSESSMENT SCORE FOR PREDICTING DISEASE RELAPSE IN OLDER ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS: RESULTS FROM A PROSPECTIVE ITALIAN SINGLE-CENTER STUDY.

EHA Library, Eugenia Accorsi Buttini, 4161115

THE STUDY ON THE CORRELATION BETWEEN DONOR CHEMOKINE RECEPTOR GENE POLYMORPHISM AND ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Tao Wu, 4161117

SAFETY AND EFFICACY OF GCSF ALONE WITH PRE-EMPTIVE PLERIXAFOR FOR AUTOLOGOUS PERIPHERAL BLOOD HEMATOPOIETIC STEM CELL MOBILIZATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Mohamed Elemary, 4161120

OUTCOMES BETWEEN SECONDARY AND DE NOVO ACUTE MYELOID LEUKEMIA IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH MYELOABLATIVE CONDITIONING IN FIRST COMPLETE REMISSION: A PROPENSITY SCORE-MATCHED STUDY.

EHA Library, Nan Yang, 4161127

AMBULATORY DELIVERY OF AUTOLOGOUS STEM CELL TRANSPLANT WITH BEAM CONDITIONING IS SAFE AND RESULTS IN REDUCED INPATIENT STAYS

EHA Library, Pierre McCarthy, 4161132

LONG-TERM FOLLOW-UP AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

EHA Library, Baazizi Mounira, 4161133

A NEW RISK FACTOR FOR POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN PEDIATRIC RECIPIENTS: LOWER CD4 T CELL COUNTS AROUND 30 DAYS AFTER HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Yangyang Gao, 4161135

CHARACTERISTICS AND OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ERCC6L2-ASSOCIATED BONE MARROW FAILURE AND MYELOID MALIGNANCIES: SINGLE-CENTER REPORT OF 9 CASES

EHA Library, Alfadil Haroon, 4161136

PREDICTORS OF OUTCOMES IN ACUTE MYELOID LEUKEMIA WITH KMT2A REARRANGEMENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Betul Oran, 4161139

ANALYSIS OF THE DIAGNOSTIC VALUE OF METAGENOMIC NEXT-GENERATION SEQUENCING (MNGS) FOR INFECTIONS FOLLOWING THE HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Yang Yan, 4161141

DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL FOR SEVERE PRE-ENGRAFTMENT SYNDROME DURING THE TREATMENT OF UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC PATIENTS

EHA Library, shiyuan wang, 4161145

ANALYSIS OF BASELINE AND CLINICAL CHARACTERISTICS OF EUROPEAN AND ITALIAN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE: INSIGHTS INTO CURRENT TREATMENT LANDSCAPE IN ITALY

EHA Library, Francesca Bonifazi, 4161147

SPLENOMEGALY AND LOW CD34+ CELL DOSE ARE ASSOCIATED WITH POOR GRAFT FUNCTION FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MYELOFIBROSIS

EHA Library, Portia Smallbone, 4161149

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING DECEASED DONOR DERIVED CRYOPRESERVED BONE MARROW: A FIRST-IN-HUMAN REPORT OF SUCCESSFUL ENGRAFTMENT IN PRESERVE 1

EHA Library, Sagar Patel, 4161153

SEQUENTIAL ALLOGENEIC STEM CELL TRANSPLANTATION FOR VENETOCLAX-EXPOSED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS-2

EHA Library, Andrius Žučenka, 4161161

SAFETY AND EFFICACY OF POMALIDOMIDE AND AZACITIDINE COMBINATION IN MRD-GUIDED PREEMPTIVE TREATMENT OF ACUTE LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Lu Wang, 4161162

HYPERTENSION IS UNDERDIAGNOSED AND ASSOCIATED WITH THE PRESENCE OF SUBCLINICAL VASCULAR DAMAGE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Wejdan Bin Obaid, 4161163